To further validate on-target functional inhibition of CtBP oncogenic activities by the 4-Cl-HIPP/GMX1778 combination relevant to tumor progression, we studied how combined CtBP/NAMPT inhibition impacts PDAC cell migration using a modified wound-healing assay (Fig. 4B). The gene discussed is NAMPT; the disease is neoplasm.